This will be Pete Abraham of the Boston Globe’s third year as a Hall of Fame voter. In year one he decided no suspected steroid users will ever get his vote. In year two he softened his stance, only withholding votes from players who were documented steroid users. This year, however, he has decided that it’s time to end all of that: PED use will not be a part of his analysis going forward. It will be all about what happened on the field.
Go read his column about his new approach. Note that, in changing his view of the matter, he is in no way endorsing PED use or absolving players of their cheating ways. He’s merely acknowledging that PEDs were a reality of the sport for a long time, that there are limits to what a voter can know, that consistency is important and that, ultimately, it is not the place of a baseball writer to become a judge of character as much as he or she is a judge of baseball prowess.
This is encouraging.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.